J Frontier Co.,Ltd.

2934.T
Pharmaceutical Retailers
2026/09/21 Updated
Market Cap: $69.2M (¥10.9B)
Stock Price: $12.97 (¥2,039)
Exchange Rate: 1 USD = ¥157.23

Matters Concerning Business Plan and Growth Potential

Leading with the SOKUYAKU business aiming to exceed the operating income progress beyond the mid-term plan, driven by price revision and strengthened alliances to propel profit growth in FY27/5. Promote expansion of D2C/healthcare sectors and domestic and international market development.

Importance:
Page Updated: August 31, 2026
IR Disclosure Date: August 31, 2026

Key Figures

  • Sales 22,235 million yen (Actual, up 3.4% YoY)
  • EBITDA 964 million yen (Actual, up 7.1% YoY)
  • Operating income 312 million yen (Actual, up 6.3% YoY)

AI要約

Section Heading

Progress of the mid-term management plan and growth strategy; explains revenue and profitability growth outlook centered on the SOKUYAKU business, with price revisions, expanded alliances, and expansion of the D2C area.

Section 2 Heading

Financial highlights and segment-by-segment performance analysis. Factors for profitability improvement centered on SOKUYAKU, and growth outlook from partnerships and market expansion.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

J Frontier Co.,Ltd.

Company overview · Stock price · Financial data · All IR

View company page →